Press release
Global Lipid Metabolism Disease Drug Market, Size, Share, Analysis Report & Forecast to 2026
The global lipid metabolism disease drug market is estimated to grow at a CAGR of nearly XX% during the forecast period. The key factor driving the growth of the global lipid metabolism disease drug market includes the rising prevalence of lipid metabolism disorders and increasing adoption of an unhealthy lifestyle. According to the National Organizations of Rare Disorders, in 2018, lipid metabolism disorders such as Gaucher disease accounted for the 6,000 patients in the US and accounting for more than 90% of cases among Caucasians. It is a liposomal storage disorder in which due to the lack of enzyme glucocerebrosidase, certain sugars containing fats get accumulated in the body.Free Sample Copy @ https://www.omrglobal.com/request-sample/lipid-metabolism-disease-drug-market
The lipid metabolism disorders such as Gaucher disease, Niemann-Pick Disease, and Tay-Sachs disease, include lipids which are fats or fats-like substances including fatty acids, oils, waxes, and cholesterol. In this disorder, the body fails to convert fats into energy that subsequently leads to the accumulation of fats in the body which damages the various parts of the body including the liver, spleen, brain, peripheral nervous system, and many more. There are several FDA-approved drugs for the treatment of lipid metabolism disorders. For instance, Cerdelga (eliglustat) manufactured by Genzyme, was approved by the US FDA in 2014, for the long-term treatment of patients suffering from Gaucher disease. In the past few years, new drugs such as icosaapent ethyl, bempedoic acid, are being tested for the treatment of statin tolerated patients and has shown huge potential.
A Full Report of Global Lipid Metabolism Disease Drug Market is Available at:
https://www.omrglobal.com/industry-reports/lipid-metabolism-disease-drug-market
The key players contributing to the growth of the global lipid metabolism disease drug market by adopting various strategies such as product launches & developments, mergers and acquisition, partnerships, and agreements, include Merck Group, Novartis AG, Takeda Pharmaceutical, AstraZeneca, Boehringer Ingelheim, KOWA, Kythera, Fuji yakuhin, LG Life Science, Mitsubishi Tanabe Pharma among others. For instance, in 2019, Investigational New Drug (IND) application by IntraBio Inc. was approved by the US FDA for the clinical trial of IB1001-202 containing lead compound (IB1001) for the treatment of Tay-Sachs disease and Sandhoff Disease.
Global Lipid Metabolism Disease Drug Market – Segmentation
By Type
OTC
Rx Drugs
By Application
Lipoprotein disorders
Fatty acid oxidation defects
Mitochondrial disorders
Lysosomal storage disorders
Peroxisomal disorders
Purine and pyrimidine disorders
Porphyria’s
By Distribution Channel
Hospital
Retail Pharmacy
Online
Others
Global Lipid Metabolism Disease Drug Market – Segmentation by Region
North America
United States
Canada
Europe
Germany
United Kingdom
France
Spain
Italy
Rest of Europe
Asia-Pacific
China
Japan
India
Rest of Asia-Pacific
Rest of the World
Company Profiles
Merck KGaA
Novartis AG
Takeda Pharmaceutical Company Ltd.
AstraZeneca Plc.
Boehringer Ingelheim
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/lipid-metabolism-disease-drug-market
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 780-304-0404
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Lipid Metabolism Disease Drug Market, Size, Share, Analysis Report & Forecast to 2026 here
News-ID: 2418925 • Views: …
More Releases from Orion Market Research
Hair Accessories Market Poised for Strong Growth Driven by Gen Z Trends and Sust …
Hair accessories market was valued at $23.8 billion in 2024 and is projected to reach $55.2 billion in 2035, growing at a CAGR of 8.2% during the forecast period (2025-2035). Generation Z, with significant disposable income, is transforming the hair accessories category in a major way. Their close connection to trends creates a unique feeling of urgency to self-express through fashion, such as clips, scrunchies, and barrettes. It has become…
Railway Management System Market Size Analysis, Competitive Insights, Leading Pl …
Railway System (or Railway Management System) market was valued at approximately USD 28.28 billion, and it is expected to reach about USD 45.19 billion by 2033, growing at a CAGR of around 4.8% from 2024 to 2033.
Railway Management System Market Overview
The Railway Management System market includes technologies and systems used to plan, monitor, and manage railway operations-everything from traffic and signaling systems to asset and maintenance management, passenger information,…
Monocalcium Phosphate Market Size Analysis, Competitive Insights, Leading Player …
Monocalcium Phosphate market was valued at about USD 4.2 billion, and it is anticipated to reach around USD 6.9 billion by 2033, growing at a CAGR of approximately 5% from 2023 to 2033.
Monocalcium Phosphate Market Overview
Monocalcium phosphate (MCP) is a calcium-phosphorus compound widely used in animal feed, fertilizers, and also in food and beverage applications (for example as leavening agent or acidity regulator), due to its solubility and bioavailability. The…
Automotive Lubricants Market Size Analysis, Competitive Insights, Leading Player …
Automotive Lubricants Market was valued at approximately USD 70.44 billion. By 2033, it is expected to reach around USD 107.09 billion, growing at a CAGR of about 3.3% from 2025 to 2033.
Automotive Lubricants Market Overview
The automotive lubricants market consists of products like engine oils, gear oils, greases, hydraulic fluids, and transmission fluids that reduce friction, wear and tear, and improve efficiency and lifespan of vehicle components. Demand is driven by…
More Releases for Disease
Protheragen Announces Disease Model Development Services to Enhance Rare Disease …
Protheragen announced the release of its disease model development services provided to enhance rare disease research. With an increasing focus on rare diseases and the need for tailored research models, Protheragen is dedicated to providing cutting-edge solutions to support this important area of medical research.
Rare diseases, which affect a small percentage of the population, pose unique challenges for researchers due to their limited understanding and lack of available treatment options.…
Biopharmaceutical Fermentation Market 2022 | Growing Morbidity of Genetic Diseas …
According to Precision Business Insights (PBI), the latest report, the biopharmaceutical fermentation market is expected to be valued at USD 10,302.1 million in 2022, growing at a 4.7% CAGR from 2022 to 2028. The growing prevalence of chronic illness, cancer, cardiac diseases, infectious diseases, antibiotic resistance, autoimmune diseases, etc., globally causes the leaning toward biopharmaceutical products, which show promising results in the research studies. Moreover, new findings by the…
Global Inflammatory Bowel Disease (IBD) Market Key Players Analysis, Disease Ind …
Global Inflammatory Bowel Disease (IBD) Market, valued at USD 210.5 Billion in the year 2020 has been driven by factors such as the increasing prevalence of Ulcerative Colitis and Crohn’s Disease, advances in medical technology, government support for inflammatory bowel disease treatment research, and the ubiquity of anxiety and depression. Moreover, factors such as the irregular food habits, unhealthy lifestyle of people, increased level of pollution and increase in alcohol…
Moyamoya Disease Market - A Scientometric Assessment of Disease During 2018-23
Market Highlight:
Moyamoya disease (MMD) is a chronic, cerebrovascular disease characterized by progressive stenosis in the internal carotid artery and an abnormal vascular network at the base of the brain. The stroke is one of the significant symptoms of moyamoya disease, which further leads to paralysis of the face, arms, and legs, loss of speech, and temporary loss of neurologic function of body parts, visual disturbances, headaches, developmental delay, and…
Refsum Disease Industry An Overview of A New Disease - 2018
"Refsum Disease" is a genetic disorder which is inherited as an autosomal recessive trait. The condition is characterized by progressive loss of vision (retinitis pigmentosa), failure of muscle coordination (ataxia), degenerative nerve disease (peripheral neuropathy), and dry, rough, scaly skin (ichthyosis). The accumulation of fatty acid (phytanic acid) in blood plasma and tissues is the main cause of refsum disease. This occurs due to malfunction of the enzyme producing gene…
Chagas Disease (Infectious Disease) Pipeline Forecast Report, H1, 2017 [MRH]
Market Research Hub's Pharmaceutical and Healthcare latest pipeline guide Chagas Disease - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Chagas Disease Market (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and…
